S&P 500   4,335.92 (+0.14%)
DOW   34,024.99 (-0.13%)
QQQ   359.70 (+0.51%)
AAPL   174.70 (+0.44%)
MSFT   319.20 (-0.10%)
META   303.73 (+2.71%)
GOOGL   130.55 (+0.08%)
AMZN   131.60 (+1.76%)
TSLA   253.75 (-0.76%)
NVDA   418.32 (+1.99%)
NIO   8.56 (+1.30%)
BABA   87.73 (+4.30%)
AMD   96.66 (+0.57%)
T   15.11 (-1.31%)
F   12.48 (+2.30%)
MU   68.36 (+0.68%)
CGC   0.79 (+2.65%)
GE   112.99 (+0.00%)
DIS   82.58 (-0.18%)
AMC   7.64 (-0.78%)
PFE   32.76 (-0.27%)
PYPL   58.62 (+0.00%)
NFLX   383.99 (-0.04%)
S&P 500   4,335.92 (+0.14%)
DOW   34,024.99 (-0.13%)
QQQ   359.70 (+0.51%)
AAPL   174.70 (+0.44%)
MSFT   319.20 (-0.10%)
META   303.73 (+2.71%)
GOOGL   130.55 (+0.08%)
AMZN   131.60 (+1.76%)
TSLA   253.75 (-0.76%)
NVDA   418.32 (+1.99%)
NIO   8.56 (+1.30%)
BABA   87.73 (+4.30%)
AMD   96.66 (+0.57%)
T   15.11 (-1.31%)
F   12.48 (+2.30%)
MU   68.36 (+0.68%)
CGC   0.79 (+2.65%)
GE   112.99 (+0.00%)
DIS   82.58 (-0.18%)
AMC   7.64 (-0.78%)
PFE   32.76 (-0.27%)
PYPL   58.62 (+0.00%)
NFLX   383.99 (-0.04%)
S&P 500   4,335.92 (+0.14%)
DOW   34,024.99 (-0.13%)
QQQ   359.70 (+0.51%)
AAPL   174.70 (+0.44%)
MSFT   319.20 (-0.10%)
META   303.73 (+2.71%)
GOOGL   130.55 (+0.08%)
AMZN   131.60 (+1.76%)
TSLA   253.75 (-0.76%)
NVDA   418.32 (+1.99%)
NIO   8.56 (+1.30%)
BABA   87.73 (+4.30%)
AMD   96.66 (+0.57%)
T   15.11 (-1.31%)
F   12.48 (+2.30%)
MU   68.36 (+0.68%)
CGC   0.79 (+2.65%)
GE   112.99 (+0.00%)
DIS   82.58 (-0.18%)
AMC   7.64 (-0.78%)
PFE   32.76 (-0.27%)
PYPL   58.62 (+0.00%)
NFLX   383.99 (-0.04%)
S&P 500   4,335.92 (+0.14%)
DOW   34,024.99 (-0.13%)
QQQ   359.70 (+0.51%)
AAPL   174.70 (+0.44%)
MSFT   319.20 (-0.10%)
META   303.73 (+2.71%)
GOOGL   130.55 (+0.08%)
AMZN   131.60 (+1.76%)
TSLA   253.75 (-0.76%)
NVDA   418.32 (+1.99%)
NIO   8.56 (+1.30%)
BABA   87.73 (+4.30%)
AMD   96.66 (+0.57%)
T   15.11 (-1.31%)
F   12.48 (+2.30%)
MU   68.36 (+0.68%)
CGC   0.79 (+2.65%)
GE   112.99 (+0.00%)
DIS   82.58 (-0.18%)
AMC   7.64 (-0.78%)
PFE   32.76 (-0.27%)
PYPL   58.62 (+0.00%)
NFLX   383.99 (-0.04%)
NYSE:CC

Chemours (CC) Stock Forecast, Price & News

$30.50
+0.07 (+0.23%)
(As of 09:45 AM ET)
Compare
Today's Range
$30.46
$30.69
50-Day Range
$30.43
$38.61
52-Week Range
$23.58
$39.05
Volume
13,168 shs
Average Volume
1.24 million shs
Market Capitalization
$4.52 billion
P/E Ratio
N/A
Dividend Yield
3.28%
Price Target
$38.22

Chemours MarketRank™ Forecast

Analyst Rating
Hold
2.10 Rating Score
Upside/​Downside
25.6% Upside
$38.22 Price Target
Short Interest
Healthy
3.31% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.27mentions of Chemours in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
20.12%
From $3.38 to $4.06 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.68 out of 5 stars

Basic Materials Sector

37th out of 165 stocks

Chemicals & Allied Products Industry

7th out of 15 stocks


CC stock logo

About Chemours (NYSE:CC) Stock

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and other applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

CC Price History

CC Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
Chemours Company (CC) Receives a Hold from RBC Capital
F-Gases: A Critical Link to Decarbonization
BMO Capital Keeps Their Buy Rating on Chemours Company (CC)
Barclays Keeps Their Hold Rating on Chemours Company (CC)
BMO Capital Sticks to Their Buy Rating for Chemours Company (CC)
Q2 2023 Chemours Co Earnings Call
CC The Chemours Company
See More Headlines
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Company Calendar

Last Earnings
7/28/2023
Ex-Dividend for 9/15 Dividend
8/14/2023
Dividend Payable
9/15/2023
Today
9/22/2023
Next Earnings (Estimated)
10/24/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Fax
N/A
Employees
6,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$38.22
High Stock Price Forecast
$53.00
Low Stock Price Forecast
$25.00
Forecasted Upside/Downside
+25.6%
Consensus Rating
Hold
Rating Score (0-4)
2.10
Research Coverage
10 Analysts

Profitability

Net Income
$578 million
Pretax Margin
-0.48%

Debt

Sales & Book Value

Annual Sales
$6.79 billion
Cash Flow
$6.73 per share
Book Value
$7.34 per share

Miscellaneous

Free Float
145,663,000
Market Cap
$4.51 billion
Optionable
Optionable
Beta
1.98
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Mark E. NewmanMr. Mark E. Newman (Age 60)
    CEO, Pres & Director
    Comp: $2.17M
  • Mr. David C. Shelton Esq.Mr. David C. Shelton Esq. (Age 59)
    Legal Advisor
    Comp: $845.64k
  • Ms. Denise M. DignamMs. Denise M. Dignam (Age 57)
    Pres of Titanium Technologies
    Comp: $977.06k
  • Mr. Jonathan S. Lock (Age 42)
    Section 16 Officer, Sr. VP & CFO
  • Ms. Camela T. Wisel (Age 48)
    VP, Chief Accounting Officer & Controller
  • Mr. Brandon Ontjes
    VP of FP&A and Investor Relations
  • Ms. Kristine M. Wellman (Age 54)
    Sr. VP, Gen. Counsel & Company Sec.
  • Ms. Alvenia ScarboroughMs. Alvenia Scarborough (Age 49)
    Sr. VP of Corp. Communications & Chief Brand Officer
  • Ms. Susan M. Kelliher (Age 56)
    Sr. VP of People
  • Mr. Matthew S. AbbottMr. Matthew S. Abbott (Age 46)
    Sr. VP & Chief Enterprise Transformation Officer













CC Stock - Frequently Asked Questions

Should I buy or sell Chemours stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 1 sell rating, 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View CC analyst ratings
or view top-rated stocks.

What is Chemours' stock price forecast for 2023?

10 brokerages have issued twelve-month price objectives for Chemours' stock. Their CC share price forecasts range from $25.00 to $53.00. On average, they predict the company's stock price to reach $38.22 in the next twelve months. This suggests a possible upside of 25.6% from the stock's current price.
View analysts price targets for CC
or view top-rated stocks among Wall Street analysts.

How have CC shares performed in 2023?

Chemours' stock was trading at $30.62 at the start of the year. Since then, CC stock has decreased by 0.6% and is now trading at $30.43.
View the best growth stocks for 2023 here
.

Are investors shorting Chemours?

Chemours saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 4,840,000 shares, a drop of 10.4% from the August 15th total of 5,400,000 shares. Based on an average daily volume of 1,390,000 shares, the short-interest ratio is currently 3.5 days. Approximately 3.3% of the shares of the company are sold short.
View Chemours' Short Interest
.

When is Chemours' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, October 24th 2023.
View our CC earnings forecast
.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) announced its quarterly earnings data on Friday, July, 28th. The specialty chemicals company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $0.01. The specialty chemicals company earned $1.64 billion during the quarter, compared to analyst estimates of $1.75 billion. Chemours had a negative net margin of 1.40% and a positive trailing twelve-month return on equity of 46.14%. During the same period in the previous year, the firm posted $1.89 earnings per share.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours announced a quarterly dividend on Wednesday, July 26th. Investors of record on Tuesday, August 15th will be paid a dividend of $0.25 per share on Friday, September 15th. This represents a $1.00 annualized dividend and a yield of 3.29%. The ex-dividend date is Monday, August 14th.
Read our dividend analysis for CC
.

Is Chemours a good dividend stock?

Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.22%.
Read our dividend analysis for CC.

What guidance has Chemours issued on next quarter's earnings?

Chemours updated its FY 2023 earnings guidance on Friday, July, 28th. The company provided earnings per share guidance of $3.27-$3.60 for the period, compared to the consensus earnings per share estimate of $4.02. The company issued revenue guidance of -.

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Who are Chemours' major shareholders?

Chemours' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (11.52%), Bank of New York Mellon Corp (3.77%), State Street Corp (2.95%), JPMorgan Chase & Co. (2.36%), LSV Asset Management (1.89%) and Dimensional Fund Advisors LP (1.71%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott, Matthew S Abbott and Sameer Ralhan.
View institutional ownership trends
.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $30.43.

How much money does Chemours make?

Chemours (NYSE:CC) has a market capitalization of $4.51 billion and generates $6.79 billion in revenue each year. The specialty chemicals company earns $578 million in net income (profit) each year or ($0.68) on an earnings per share basis.

How many employees does Chemours have?

The company employs 6,600 workers across the globe.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The official website for the company is www.chemours.com. The specialty chemicals company can be reached via phone at (302) 773-1000 or via email at investor@chemours.com.

This page (NYSE:CC) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -